Literature DB >> 11134923

The three-dimensional structure of human S100A12.

O V Moroz1, A A Antson, G N Murshudov, N J Maitland, G G Dodson, K S Wilson, I Skibshøj, E M Lukanidin, I B Bronstein.   

Abstract

The crystal structure of human EF-hand calcium-binding protein S100A12 in its calcium-bound form has been determined to 1.95 A resolution by molecular replacement using the structure of the S100B protein. The S100 family members are homologous to calmodulin and other related EF-hand calcium-binding proteins. Like the majority of S100 proteins, S100A12 is a dimer, with the interface between the two subunits being composed mostly of hydrophobic residues. The fold of S100A12 is similar to the other known crystal and solution structures of S100 proteins, except for the linker region between the two EF-hand motifs. Sequence and structure comparison between members of the S100 family suggests that the target-binding region in S100A12 is formed by the linker region and C-terminal residues of one subunit and the N-terminal residues of another subunit of the dimer. The N-terminal region of the target-binding site includes two glutamates that are conserved in most of the S100 sequences. The comparison also provided a better understanding of the role of the residues important for intra- and inter-subunit hydrophobic interactions. The precise role of S100A12 in cell behaviour is yet undefined, as is the case for the whole family, although it has been shown that the interaction of S100A12 with the RAGE receptor is implicated in inflammatory response.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11134923     DOI: 10.1107/s090744490001458x

Source DB:  PubMed          Journal:  Acta Crystallogr D Biol Crystallogr        ISSN: 0907-4449


  26 in total

1.  ANTI-INFECTIVE PROTECTIVE PROPERTIES OF S100 CALGRANULINS.

Authors:  Kenneth Hsu; Chantrakorn Champaiboon; Brian D Guenther; Brent S Sorenson; Ali Khammanivong; Karen F Ross; Carolyn L Geczy; Mark C Herzberg
Journal:  Antiinflamm Antiallergy Agents Med Chem       Date:  2009-12-04

2.  Solution structure of human Ca(2+)-bound S100A12.

Authors:  Kuo-Wei Hung; Chan-Chia Hsu; Chin Yu
Journal:  J Biomol NMR       Date:  2013-09-22       Impact factor: 2.835

3.  Purification, crystallization and preliminary X-ray diffraction of human S100A15.

Authors:  Karen M Boeshans; Ronald Wolf; Christopher Voscopoulos; William Gillette; Dominic Esposito; Timothy C Mueser; Stuart H Yuspa; Bijan Ahvazi
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2006-04-21

Review 4.  Calcium-dependent and -independent interactions of the S100 protein family.

Authors:  Liliana Santamaria-Kisiel; Anne C Rintala-Dempsey; Gary S Shaw
Journal:  Biochem J       Date:  2006-06-01       Impact factor: 3.857

5.  Characterization and engineering of S100A12-heparan sulfate interactions.

Authors:  Xiaoxiao Zhang; Chihyean Ong; Guowei Su; Jian Liu; Ding Xu
Journal:  Glycobiology       Date:  2020-07-20       Impact factor: 4.313

6.  The Calcium-Dependent Interaction of S100B with Its Protein Targets.

Authors:  Danna B Zimmer; David J Weber
Journal:  Cardiovasc Psychiatry Neurol       Date:  2010-08-17

7.  S100A1: Structure, Function, and Therapeutic Potential.

Authors:  Nathan T Wright; Brian R Cannon; Danna B Zimmer; David J Weber
Journal:  Curr Chem Biol       Date:  2009-05-01

8.  Structure of Ca2+-bound S100A4 and its interaction with peptides derived from nonmuscle myosin-IIA.

Authors:  Vladimir N Malashkevich; Kristen M Varney; Sarah C Garrett; Paul T Wilder; David Knight; Thomas H Charpentier; Udupi A Ramagopal; Steven C Almo; David J Weber; Anne R Bresnick
Journal:  Biochemistry       Date:  2008-04-15       Impact factor: 3.162

9.  Bioinorganic Explorations of Zn(II) Sequestration by Human S100 Host-Defense Proteins.

Authors:  Lisa S Cunden; Elizabeth M Nolan
Journal:  Biochemistry       Date:  2018-03-06       Impact factor: 3.162

10.  TLS from fundamentals to practice.

Authors:  Alexandre Urzhumtsev; Pavel V Afonine; Paul D Adams
Journal:  Crystallogr Rev       Date:  2013-07-01       Impact factor: 2.467

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.